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GLUTAMATE TRANSPORTER MODULATION OF AMBIENT AND SYNAPTIC 
GLUTAMATE LEVELS!
Chairperson: Michael P. Kavanaugh, Ph.D.!
Abstract 
Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. 
An accurate spatial and temporal glutamate concentration profile during signaling is crucial for 
reliable neural computation. In these studies, we investigated the roles of glutamate transporters 
in controlling both ambient glutamate levels and dynamic glutamate concentrations profiles 
during synaptic transmission. Using the Xenopus oocyte expression system, we demonstrated 
that glutamate transporters act as an effective sink and are capable of maintaining >200 fold 
glutamate concentration gradient between the bath and cell surface when expressed at levels 
corresponding to physiological transporter densities in the CNS. We also characterized the 
specificity and actions of a new arylasparate glutamate transport inhibitor at the Shaffer 
collateral-CA1 pyramidal cell synapse in hippocampus, and demonstrated that glial glutamate 
transporters tightly control synaptically released glutamate and further, through cooperation with 
voltage-dependent Mg2+ block, they influence the magnitude and frequency-dependence of 
postsynaptic NMDA receptor signaling. 
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CHAPTER 1 : BACKGROUND AND SIGNIFICANCE 
Glutamate transporter subtypes and expression density. 
 Glutamate is considered to be the major excitatory neurotransmitter involved in most 
aspects of normal brain functions including neural development, cognition, learning and 
memory. (Danbolt, 2001). Due to the importance of glutamate in excitatory signaling, its actions 
need to be tightly regulated.  Elevated glutamate levels under neurological diseases such as 
stroke and epilepsy can cause significant activation of NMDA receptors and Ca2+ entry, which 
lead to excitotoxicity and eventually cell death. Unlike acetylcholine which is enzymatically 
degraded after release, glutamate must be actively taken up intracellularly by glutamate 
transporters. Five major subtypes of glutamate transporters exist in the CNS, EAAT1-5. EAAT1 
(GLAST) and EAAT2 (GLT-1) are the only glutamate transporters expressed in brain astrocytes, 
EAAT3 (EAAC1) and EAAT4 are predominately neuronal, whereas EAAT5 is preferentially 
expressed in the retina (Lehre and Danbolt, 1998; Danbolt, 2001).  EAAT1 and EAAT2 are 
densely expressed in both hippocampus and cerebellum, with the numbers of EAAT1 and 
EAAT2 3200 and 12,000 per µm3  in the stratum radiatum of adult rat hippocampus and 18,000 
and 2800 in the cerebellar molecular layer, respectively (Lehre and Danbolt ,1998). Glutamate 
transporters expressed near a single release site greatly out number the glutamate molecules 
released by a synaptic vesicle (~3000 molecules per vesicle). 
                                      
                        
!!!!!!!!!!!!
 1
Table 1.1, Summary of transporter surface and volumetric density of GLAST and GLT-1 in CA1 
hippocampus and molecular layer of cerebellum (Lehre and Danbolt , 1998). !!
Biophysical and structural properties of glutamate transporters. 
 The glutamate transporter belongs to the class of secondary-active, sodium dependent 
transporters, which transport glutamate utilizing pre-existing ion gradients between the 
extracellular solution and cytoplasm. The stoichiometry of glutamate transport coupling is 
movement of 1 glutamate- , 3 Na+ and 1 proton into the cell along with 1 K+ out of the cell 
(Zerangue and Kavanaugh, 1996),  since 2 net charges are moved into the cell with each 
transporter cycle, this process is electrogenic (Figure 1.1).  
 !!!!!
Figure 1.1. Stoichiometry of glutamate 
transport.  Schematic of a glutamate 
transporter with coupled (Na+, K+, and H+) and 
uncoupled (Cl-) ions. (Tzingounis and Wadiche, 
2007) !
!
!
!
 In addition to coupled ions, glutamate transporters also behave as glutamate gated Cl - 
channels, and upon transport of glutamate, an anion current also pass through the transporter. 
Both of the coupled current and uncoupled anion current can be recorded when expressing 
glutamate transporter in either Xenopus oocyte system (Wadiche et al., 1995) or HEK cell line 
(Bergles et al., 2002). When puffing glutamate onto outside out patches pulled from EAAT2 
expressing HEK cells with different intracellular solutions,  kinetics comparison can be made 
between the coupled and uncoupled currents. Transporter associated anion currents has been 
shown to exhibit rise and decay time twice as slow as the coupled currents (Figure 1.2, Bergles 
et al., 2002). 
 2
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Figure 1.2. Comparison of coupled and uncoupled responses elicited by L-glutamate.  A) 
L-Glutamate-evoked (10mM) transporter current from an outside-out patch recorded in the 
absence of permeant anions (K-gluconate-based internal solution.) B) L-Glutamate-evoked 
(10mM) transporter current from an outside-out patch recorded in the presence of permeant 
anions (KSCN-based internal solution.) (Bergles et al., 2002) !
Currents recorded during these electrogenic processes are important indexes reflecting protein 
conformation changes associated with glutamate binding and transport. Transporter currents 
measured from recombinantly or natively expressed glutamate transporters have provided us 
some important knowledge of the transporter kinetics. Binding of glutamate to the transporters 
has been shown to be very rapid, on the order of 107M-1s-1 (Otis and Jahr, 1998; Wadiche and 
Kavanaugh, 1998; Grewer et al., 2000), similar to the binding rate of glutamate to AMPARs and 
NMDARs; glutamate translocation can be as rapid as 1-3ms in GLT-1 (Otis and Kavanaugh, 
2000). The rate limiting step of glutamate transport has been purposed to be the transport 
turnover rate: at physiological potentials (-80mV to -90mV) the turnover rate of EAAT2 was 
estimated to be 100s-1 (Bergles and Jahr, 1998; Bergles et al., 2002) which is around 1.5 times 
and 6 times faster than the turnover rates for EAAT3 and EAAT1 (Grewer et al., 2000; Wadiche 
and Kavanaugh, 1998). These slow turnover rate estimates raised the questions that how 
transporters regulate the spatiotemporal profile of the glutamate concentration profile in the 
synaptic cleft on the time scale of a few milliseconds when the turnover rate is so slow (~10ms - 
 3
60ms).  One hypothesis suggests that instead of removing glutamate molecules by glutamate 
translocation, glutamate transporters effectively reduce glutamate concentration mainly by 
ligand binding (Tong and Jahr, 1994). With 15200 glutamate transporters per µm3  in 
hippocampal neuropil (Lehre and Danbolt, 1998), 3000 molecules released from a single vesicle 
can be effectively removed from the extracellular space by binding within 100µs. Besides 
glutamate transporters’ fast binding rate and high density, a low capture efficiency also makes 
them an ideal buffer for g lutamate. Capturing efficiency is defined as the probability of  a 
glutamate molecules bound to a glutamate transporter will be transported into the cytosol rather 
than be unbound back into the extracellular space. Capturing efficiency for EAAT1-3 has been 
determined by kinetic modeling to be approximately 0.5 (Wadiche and kavanaugh, 1998; 
Bergles et al., 2002; Tzingounis, 2002) . This suggests that a bound glutamate molecule is likely 
to unbind from one transporter and release back to the extracellular space and encounter other 
transporters until being transported.  Low capturing efficiency helps effectively localizing the 
glutamate signal by spreading glutamate sequestering tasks among a focal region instead of 
overwhelm the transporters in immediate region of release. Different translocation rate of the 
subtypes of glutamate transporter can further fine tune the system by mixing “buffers” (low 
capture efficiency) with “transporters” (high capture efficiency) and be effective at modulating 
both fast and slow glutamate signals (buffer and transport are contrasted in Figure 1.3). In the 
hippocampus, EAAT1 and EAAT2 may function as different roles according to their kinetics. Due 
to EAAT2 faster transport rate (Bergles et al., 2002) , it may work mainly as sinks to keep low 
ambient glutamate levels, whereas EAAT1 works as buffers and play an more important role 
during synaptic transmission.  
!
!
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Figure 1.3. Comparison of buffer mode and transport mode of glutamate transporters.  In 
buffer mode, a bound glutamate molecule is more like to unbind than being transported. On the 
contrary, in transport mode, a bound glutamate molecule is more likely to be transported than  to 
unbind. (Tzingounis and Wadiche, 2007) !
                                    
 The crystal structure of a bacterial glutamate transporter homologue was solved by 
Yernool et al. in 2004 and provided new insights on mechanisms of glutamate transport. This 
structure shows that glutamate transporters are homomers composed of three identical subunits 
which form a significant bowl shape structure that extends halfway across the membrane bilayer 
(Figure 1.4).  This central cavity within glutamate homotrimer protein has been proposed to 
reduce the energy for transport (Gouaux and MacKinnon 2005) and restrict ligand diffusion 
(Leary et al., 2011). Leary et al. demonstrated that the unbinding rate of an EAAT3 ligand 2-FAA 
was 9 times faster when co-applied with saturating concentration of glutamate than the 
unbinding rate when no glutamate was applied; this suggests the central cavity restrict 
glutamate unbinding from the protein. Effects of the bowl would further increase the complexity 
of the transporter kinetics, since ligand unbinding rate is no longer constant with varying [Glu] 
but changing with the occupancy of transporter subunits. 
!
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Figure 1.4. The crystal structure of a bacterial glutamate transporter. a) A ribbon 
representation of Gltph, viewed from the extracellular side of the membrane. b) A view of the 
trimer from the cytoplasm. c) A view of the trimer from the plane of the membrane. d) A surface 
representation of the trimer sliced through the center. Polar and non-polar residues are colored 
cyan and white. (Yernool et al., 2004; Tzingounis and Wadiche, 2007) !
Ambient glutamate levels and tonic glutamate release in the brain. 
 Based on the thermodynamic coupling of glutamate transporter, an extracellular [Glu] as 
low as 2nM can be maintained in the absence of glutamate release (Zerangue and Kavanaugh, 
1996; Levy et al. 1998). However, tonic activation of NMDAR by ambient glutamate has been 
observed (Sah et al. 1989; Cavelier and Attwell, 2005; Herman and Jahr, 2007), and ambient 
glutamate level in the hippocampus was estimated to be on the order of 25nM. In addition, 
microdialysis measurements in vivo reported extracellular [Glu] on the order of 2µM (Benveniste 
et al., 1984; Lerma et al., 1986; for reviews see Cavelier et al., 2005, Nyatrai et al., 2006). This 
suggests a constant release of glutamate is present in vivo and this constant release is 
 6
considered to be of glial origin (Jabaudon et al. 1999, Cavalier et al., 2005). An accurate 
estimation of ambient [Glu] is important since ambient [Glu] levels significantly influence the 
extent of activation and desensitization of glutamate receptors (Figure 1.5).  
!
                 
!  
Figure 1.5. Glutamate concentration-dependance of ionotropic and metabotropic 
receptor activation. NMDAR data (logistic fit, n=1.5) from Patneau and Mayer, 1990. 
Representative high affinity members of group I-III metabotropic receptor affinities from Pin and 
Duvoisin, 1995. Dashed line shows glutamate concentration-dependance of inhibition of 
synaptic NMDAR signaling in cultured neurons, reflecting pre- and post-synaptic mechansisms 
(Zorumski et al., 1996). !!!!!!!!!!!
2nM (Zerangue and 
Kavanaugh, 1996) 
25nM (Herman and Jahr, 
2007) 2µM (microdialysis) 
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Glutamate transporter’s roles on synaptic transmission. !
 In addition to glutamate transporter’s  role on keeping low tonic glutamate levels, they 
also help to shape phasic glutamate signal during synaptic transmission. The effects of 
glutamate transporters on synaptic signals differ from one synapse to another, as examples, the 
hippocampal CA3-CA1 synapse and cerebellar Purkinje cell synapses will be discussed.  
                      "  
Figure. 1.6.  Schematic diagrams of the glutamatergic CA1 hippocampal synapse and the 
cerebellar Purkinje cell synapse showing the predominat pre- and postsynaptic locations and 
glial cell locations of the EAAT subtypes. (Vandenberg and Ryan, 2013) !
Hippocampal  CA3-CA1 synapse 
 Earlier studies using substrate inhibitors such as L-trans-PDC concluded that both 
AMPAR and NMDAR post-synaptic responses are not regulated by glutamate transporters and 
diffusion is the major mechanism for fast glutamate clearance (Hestrin et al., 1990; Sarantis et 
al., 1993; Isaacson and Nicoll, 1993). With the development of non-substrate transporter 
blockers such as TBOA (Shimamoto et al., 1998), TFB-TBOA (Shimamoto et al., 2004) and L-
TBA (Esslinger et al., 2005), the roles of glutamate transporter on AMPAR and NMDAR 
responses were revealed. And currently, the consensus for glutamate transporter’s role in 
synaptic transmission is that glutamate uptake does not acutely shape AMPAR responses but 
significantly limits NMDAR activation (Tzingounis and Wadiche, 2007); When recorded in 0 Mg2+ 
 8
or depolarized potentials (eg. +40mV)  transporters block by these non-substrate inhibitors 
caused a significant prolongation of NMDAR EPSCs, in contrast, AMPAR EPSC kinetics are not 
significantly altered except when desensitization is blocked (Tsukada et al., 2005). However, 
glutamate transporter’s roles under physiological conditions (non-voltage clamp, with 
physiological Mg2+) are less well characterized. The aim of chapter 3 and 4 of this dissertation is 
to betters understand how transporters modulate NMDAR and AMPAR responses under 
physiological conditions. 
!
Cerebellar synapses 
 In contrast to CA3-CA1 synapses which are only marginally covered by glial processes 
(less than 50%, Ventura and Harris, 1999), the cerebellar Bergmann glial cells closely appose 
Purkinje cell synapses (Spacek, 1985, Figure 1.6). This unique spatial arrangement of glial 
processes not only provide a physical barrier between neighboring synapses, but also bring 
transporters closer to release sites; this also support the fact that transporter blockers have 
more robust effects on cerebellar synaptic transmission than that is seen in the hippocampus. 
Transporter blockers have significantly different effects on two of the major cerebellar synapses: 
parallel fiber synapses and climbing fiber synapses. At parallel fiber synapses, transporter block 
has little effect on AMPAR EPSCs following single/sparse axonal stimulation, the effects gets 
bigger when stimulating multiple adjacent axons (Barbour et al., 1994). In contrast, glutamate 
transporters limit the time course of AMPAR activation following a single synaptic stimulation 
(Wadiche and Jahr, 2001). In addition to glial transporter EAAT1 and EAAT2, neuronal 
transporter EAAT4 also plays an important role in controlling cerebellar synaptic transmission. 
Evidences have suggest that EAAT4 limits extrasynaptic receptor activation by buffering 
synaptically released glutamate (Tsai et al., 2012). 
!
 In summary, glutamate transporters with different kinetics long with specific extracellular 
morphologies cooperatively shape the profile of synaptically released glutamate. 
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CHAPTER 2: GLUTAMATE TRANSPORTER CONTROL OF AMBIENT GLUTAMATE LEVELS 
Weinan Sun, Denis Shchepakin, Leonid V. Kalachev and Michael P. Kavanaugh 
!
Abstract  
 Accurate knowledge of the ambient extracellular glutamate concentration in brain is 
required for an understanding of its potential impact on tonic and phasic receptor signaling. 
Estimates of ambient glutamate based on microdialysis measurements are  generally in the 
range of ~2-7 µM, approximately 100-fold higher than estimates based on electrophysiological 
measurements of tonic NMDA receptor activity (25-90 nM). The latter estimates are closer to the 
estimated thermodynamic limit of glutamate transporters (2 nM). The reasons for this 
discrepancy are not known, but it has been suggested that microdialysis measurements could 
overestimate ambient extracellular glutamate because of reduced glutamate transporter activity 
in a region of metabolically impaired neuropil adjacent to the dialysis probe. We explored this 
issue by measuring diffusion gradients created by varying densities of glutamate transporters 
expressed in Xenopus oocytes. With free diffusion from a fixed 10 µM glutamate source, the 
surface concentration of glutamate depended on transporter density and was reduced over 2 
orders of magnitude by transporters expressed at membrane density levels similar to those 
reported in hippocampus. We created a diffusion model to simulate the effect of transport 
impairment on microdialysis measurements with boundary conditions corresponding to a 100 
µm radius probe. A gradient of metabolic disruption in a thin (~100 µm) region of neuropil 
adjacent to the probe increased predicted [Glu] in the dialysate over 100-fold. The results 
provide support for electrophysiological estimates of submicromolar ambient extracellular [Glu] 
in brain and provide a possible explanation for the higher values reported using microdialysis 
approaches. 
!
!
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Introduction 
 During synaptic transmission, glutamate transporters restrict the spatiotemporal pattern 
of ionotropic and metabotropic glutamate receptor signaling (for review see Tzingounis and 
Wadiche, 2007). In addition to their roles in shaping the dynamics of synaptically released 
glutamate, glutamate transporters also help maintain low steady-state glutamate levels. Given 
the stoichiometry of ion coupling to glutamate uptake, the theoretical lower limit of extracellular 
glutamate in brain is approximately 2 nM (Zerangue and Kavanaugh, 1996; Levy et al., 1998). 
Many studies using intracerebral microdialysis have reported levels of ambient glutamate ≥ 2 
µM, three orders of magnitude higher than the theoretical lower limit (Benveniste et al., 1984; 
Lerma et al., 1986; for reviews see Cavelier et al., 2005, Nyatrai et al., 2006). By contrast, 
reports of ambient glutamate concentration estimated from electrophysiological measurement of 
tonic NMDA receptor activity in hippocampal slice range from 25 to 89 nM (Cavelier and Attwell, 
2005; Le Meur et al., 2007; Herman and Jahr, 2007). 
 Accurate knowledge of the ambient glutamate concentration in different brain regions is 
important for evaluating its effects on synaptic transmission. Several ionotropic and 
metabotropic glutamate receptor subtypes are activated by low micromolar concentrations of 
glutamate, and tonic exposure in this range profoundly inhibits synaptic circuitry in vitro 
(Zorumski et al., 1996). Glutamate transporters  play a dominant role in limiting ambient 
glutamate (Danbolt, 2001; Tzingounis and Wadiche, 2007). Pharmacological inhibition of 
transport has been shown to lead to a rapid increase in glutamate from largely non-vesicular 
sources, causing increased tonic NMDA receptor signaling (Jabaudon et al., 1999; Cavelier and 
Attwell, 2005; Le Meur et al., 2007, Herman and Jahr, 2007).  
 In this work we attempt to review and integrate data in the literature with new in vitro 
measurements and in vivo modeling of diffusion gradients formed by glutamate transporters. 
Proceeding from the assumption that in steady-state conditions, the volume-averaged rates of 
release and uptake of glutamate are equal, we demonstrate the strong influence of glutamate 
transporter membrane density on steady-state diffusion gradients and suggest that metabolic 
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impairment of glutamate transport in a shallow boundary region of a microdialysis probe can 
account for the discrepancies between estimates of ambient glutamate from dialysis and 
electrophysiological approaches. 
!
Materials and methods 
!
Xenopus oocyte recording 
!
Approximately 50ng of human EAAT3 cRNA was microinjected into stage V-VI Xenopus oocytes 
and recordings were made 1-6 d later. Recording solution contained 96mM NaCl, 2mM KCl, 
1mM MgCl2, 1.8mM CaCl2, and 5mM Hepes (pH 7.5). Microelectrodes were pulled to 
resistances between 1 and 3MΩ and filled with 3M KCl. Data were recorded with Molecular 
Devices amplifiers and analog-digital converters interfaced to Macintosh computers. Data were 
analyzed offline with Axograph X (v.1.0.8) and KaleidaGraph (v 3.6; Synergy) software. For 
stopped flow measurements, oocytes were voltage clamped at -60 mV in a perspex recording 
chamber in which glutamate depletion in the absence of perfusion was <1% of the total in the 
recording chamber. Transporter surface density was estimated from current measurements 
assuming a coupled current of 2 charges/cycle at ECl (-20 mV), turnover rate of 15/sec, oocyte 
surface area 2.85x107 µm2, and transport voltage-dependance of e-fold/76 mV (Wadiche et al., 
1995; Zerangue and Kavanaugh, 1996). 
!
Mathematical modeling of [Glu] profile near the microdialysis probe 
!
Our microdialysis probe model can be described by diffusion equation in polar coordinates with 
sink and leak in right hand sides: 
!
∂u/∂t = D·(1/r)· ∂/∂r [r·∂u/∂r] - J·u/(Km+u) + KL  
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where u corresponds to glutamate concentration. The first term in the right hand side is a 
Laplace operator in polar coordinates multiplied by a diffusion coefficient D. The second term 
represents the Michaelis-Menten transporter sink in the tissue, and the third term KL represents 
the leak, which is constant in damaged and healthy tissue. The parameter J is a function of 
distance from the probe center r, which describes the transporters spatial impairment between 
the healthy and damaged tissue. Because the spatial metabolic damage is approximated as a 
Gaussian curve, we define the function J as 
J(r) = 0 when 0 ≤ r ≤ L 
J(r) = Jmax·{1-e^[-(r-L)2/2·sigma2]} when r > L 
!
where L is the radial boundary for the microdialysis probe and sigma represents the distance 
from the probe boundary characterizing the Gaussian damage function. The boundary 
conditions for the model are: 
!
∂u/∂r|r=0 = 0 
u(t,∞) = us 
The initial condition is 
u(t,r) = u* when 0 ≤ r ≤ L 
u(t,r) = us when r > L 
This model cannot be solved analytically because of the nonlinear term in the right hand side of 
equation, so it was solved numerically by space discretization, which transforms it into system of 
ordinary differential equations.  
Estimation of volumetrically averaged glutamate leak in hippocampus 
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!
The leak rate constant (KL) was estimated by assuming ambient [Glu] = 25nM (Herman and 
Jahr 2007), a glutamate transporter concentration of 140µM (140-250µM, Lehre and Danbolt 
1998), a transporter KM = 25µM, and a maximal transporter turnover rate Jmax = 25 molecules/
sec  
The leak was then calculated by the equation below: 
KL  = uambient/(Km + uambient)· [GluT]·Jmax = 2100 molecules x µm-3 x sec-1  
where [GluT] is the volumetric concentration of glutamate transporters. 
!
!
Results 
!
Diffusive concentration gradients formed by glutamate transporters  
 
 Co-expression studies of NMDA receptors with transporters for its co-agonists glycine 
and glutamate have shown that transporters can limit receptor activity by establishing diffusion-
limited transmitter concentration gradients (Supplisson and Bergman, 1997; Zuo and Fang, 
2005). We studied the concentration gradients formed by passive diffusion from an quasi-infinite 
glutamate source in a perspex chamber to the glutamate sink established by transporters on the 
cell surface (see methods). Oocytes expressing the human neuronal glutamate transporter 
EAAT3 were voltage-clamped at -60 mV and superfused with varying concentrations of 
glutamate at a linear flow rate of 20 mm/sec flow followed by a stopped-flow interval (Figure 
2.1). Steady-state currents elicited by glutamate perfusion relaxed to a lower steady-state level 
when flow was stopped, and following resumption of flow, currents rapidly recovered to initial 
values. The reduction in current amplitude during zero flow conditions was likely due to the 
formation of a diffusion-limited concentration gradient resulting in reduced surface [Glu], 
because the ratio of the current amplitudes with and without flow were dependent on the 
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concentration of glutamate in the perfusate (Figure 2.1 B,C and D). This was also manifested as 
a significant shift in the KM value for glutamate measured by the concentration-dependance of 
steady-state currents in flow and stopped-flow conditions (32 ± 2 µM and 216 ± 37.0 µM, 
respectively, n=4; p=0.0014), while the Imax values were not significantly different. 
"  
Figure 2.1: Glutamate transport acts as a sink to form a concentration gradient between 
the extracellular volume and the membrane surface. A) Current induced by 10µM 
glutamate decays to a lower steady state flow under stopped-flow conditions at -60mV.  B) 
Current responses to varying [Glu] with and without flow at -60mV. C) Glutamate 
concentration-dependance of steady-state currents in flow and stopped- flow conditions. (Km 
value with flow: 32 ± 2 µM; stopped-flow: 215 ± 37 µM; n=4, p=0.0014) !
Transporter density effects on surface [Glu] 
 
 Glutamate transporters are expressed at different densities among structures in the 
CNS, and transporter density and/or kinetics can be altered in different pathological 
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circumstances such as trauma and ischemia. Because steady state ambient [Glu] reflects a 
homeostatic balance of uptake and leak sources, changes in transport may result in significantly 
different steady state glutamate levels. We tested the influence of the surface density of 
glutamate transporters on the concentration gradient formed by passive glutamate diffusion 
during stopped-flow experiments by monitoring currents induced by 10 µM glutamate. With 
increasing transporter expression levels, the steepness of the concentration gradient formed 
during stopped-flow conditions was also increased, as reflected in the changing ratio of the 
steady-state currents (Figure 2.2A,B). 
 Even with a fast flow rate, oocyte membranes have a microvillar structure that can act as 
tortuous diffusion barrier (see Supplisson and Bergman, 1997), and evidence for formation of a 
concentration gradient between the cell surface and bulk solution was observed. In a group of 
29 oocytes with varying expression levels, steady-state KM values measured with chamber flow 
(20mm/sec) increased approximately 4-fold as transporter current induced by 1mM glutamate 
increased from ~200 to ~1100 nA (Figure 2C,D). In order to accurately estimate the 
concentration of glutamate at the cell surface in stopped flow conditions by comparison of 
steady state currents with and without flow, it is necessary to correct for the effect of the 
concentration gradient that transporters establish even with high flow rates, which will cause an 
overestimation of the KM value. We fit a linear function relating the measured KM value to the 
transport current density (Barry and Diamond 1984; r=0.78; Figure 2D). Extrapolation of this line 
yielded an estimate of the intrinsic KM value of approximately 27 µM as transporter density 
approaches zero.  
!
!
!
!
!
!
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!
!  
Figure 2.2: Glutamate concentration gradients are a function of transporter density. A) 
Representative traces of stopped-flow experiments with oocytes expressing different 
transporter densities. B) Currents from cells in (A) normalized to the steady state current. C) 
Glutamate concentration-dependance of steady-state currents with low, medium and high 
expression levels. (Km values: low expression: 33µM , medium expression: 50µM and high 
expression: 98µM. Transport current amplitudes (1 mM glutamate) are 260nA, 332nA and 
688nA respectively). D), KM values from 29 oocytes with different expression levels (fitted with 
linear regression, r = 0.78; y intercept = 26.8µM).  !
!
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!
Surface [Glu] as a function of transporter density. 
!
 The dependance of steady-state KM on transporter density reflects the fact that the true 
glutamate concentration at the cell surface is reduced by uptake. However, the concentration 
difference associated with the diffusion gradient is smaller with higher applied concentrations of 
glutamate. In 29 oocytes, we recorded currents induced by 1 mM glutamate perfusion to define 
a Michaelis-Menten function for each cell, and then recorded steady-state current amplitudes in 
response to 10 µM glutamate in the chamber under stopped-flow conditions. By finding the 
glutamate concentration corresponding to each current amplitude from the Michaelis-Menten 
function, we estimated the actual glutamate surface concentration in the stopped-flow condition 
for each cell (Figure 2.3A and inset). As transporter density increased, the normalized 10µM 
glutamate amplitude diverged further from the Michaelis-Menten function, suggesting that as the 
magnitude of the sink increased, the actual surface glutamate concentration diverged further 
below 10µM. The estimated surface concentration was then plotted as a function of transporter 
density (see methods), which revealed a supralinear effect of transporter density on surface 
[Glu] (Figure 3B). Transporter density in this group of cells ranged from 234 to 5165 transporters 
per µm2. At low expression levels, the estimated [Glu] approached the chamber concentration 
(10 µM). At transporter densities of ~5000 µm-2 (approaching estimates in hippocampus of 
10800 µm-2; Lehre and Danbolt 1998), surface [Glu] was estimated to be 54 nM, roughly 185-
fold lower than [Glu] in the chamber. 
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"  
Figure 2.3: Surface [Glu] estimates as a function of transporter density. 
Surface [Glu] estimated from relative amplitude of steady state current amplitude without flow to 
the 1mM steady state glutamate current with flow fitted to Michaelis-Menten function (KM=26.8 
µM) (A, semi-log plot; inset, double-log plot) and plotted as a function of transporter density (B) 
for each oocyte at -60mV. !
Modeling the glutamate concentration profile near a microdialysis probe 
!
 We constructed a diffusion model to simulate the spatial profile of glutamate near a 
microdialysis probe (see methods). From quantitative immunoblotting, the glutamate transporter 
density in hippocampus has been estimated to be between 0.14 and 0.25 mM (Lehre and 
Danbolt, 1998). From the transporter density, glutamate transport averaged over a given volume 
of neuropil can be estimated for any given ambient glutamate value based on Michaelis-Menten 
kinetics (neglecting exchange, which becomes significant as ambient glutamate approaches the 
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equilibrium thermodynamic limit). At steady state, sources and sinks are equal, and the steady-
state leak and uptake of glutamate are equal. With ambient [Glu] = 25nM (Herman and Jahr, 
2007) and transporter density of 0.14 mM, the volume-averaged steady-state glutamate leak is 
predicted to be approximately 2100 molecules µm-3 sec-1 (but see Cavelier and Attwell, 2005). 
This tonic leak will cause increased ambient glutamate if transport is reduced as could occur in 
a metabolically impaired region of neuropil near a microdialysis probe (Clapp-Lilly, 1999; 
Bungay et al., 2003; Benveniste et al., 1987). Using the transporter density estimate from Lehre 
and Danbolt (1998) and assuming ambient [Glu] = 25 nM (Herman and Jahr 2007), we 
constructed a model with partial differential equations describing the spatial profile of [Glu] near 
a 100µm radius microdialysis probe with an adjacent region with a Gaussian gradient of 
impaired transport (Figure 4A). Although transporter reversal can occur with severely impaired 
ion gradients, we assume a constant leak in the region of damage, which may underestimate 
the effect of metabolic damage on glutamate measured in the probe. Starting the simulation at 
time = 0 with no glutamate in the interior of the probe, the glutamate concentration rises with an 
exponential time constant ~ 8.5 sec to a steady state level (data not shown). At steady state, 
[Glu] inside the probe is elevated relative to the healthy region far from the probe (Figure 2.4B1). 
With sigma = 0 (i.e. no tissue damage), [Glu] in the probe is equal to the ambient [Glu] in the 
healthy tissue.  With gradients of damage from sigma = 100 to 300 µm, steady-state glutamate 
levels in the probe range from ~3 to 10 µM (Figure 4B1).  Decreasing the glutamate diffusion 
coefficient from its value in buffer, which is higher than in brain (Kullmann et al., 1999), 
increases the predicted steady state [Glu] measured in the probe (Figure 4B2). Increasing or 
decreasing the leak rate L (Figure 4B3) also influences steady state [Glu] predicted in the probe 
volume. 
!
!
!
!
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!  
Figure 2.4: Diffusion model of transporter contribution in dialysis measurement. A1) 
Cartoon of metabolic damage in Gaussian region surrounding the microdialysis tube. A2) 
Reduced uptake rate described by the Gaussian function in the damaged region.  B) PDE 
numerical modeling describing the spatial profile of steady-state [Glu] with varying sigma (B1), 
diffusion constant (B2) and leak rate (B3).  !
Discussion 
!
 Glutamate transporters limit receptor activity on different time scales in the brain by 
restricting the spread of synaptically released glutamate as well as by maintaining low ambient 
glutamate concentrations (for reviews, see Danbolt, 2001; Tzingounis and Wadiche, 2007; 
Vandenberg and Ryan, 2013). The steady-state ambient concentration of extracellular 
glutamate at any point in brain reflects the balance of fluxes through sources and sinks in the 
neuropil. The data presented here indicate that glutamate transporters expressed on cell 
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membranes establish transporter density-dependent concentration gradients when glutamate is 
supplied by passive diffusion from an infinite source. Data presented in this work shows that at 
transporter densities similar to those reported in hippocampal membranes (~104/µm2; Lehre and 
Danbolt, 1998) the concentration gradient between a 10 µM bulk medium concentration and the 
cell surface exceed two orders of magnitude. The steepness of the gradient formed will be 
further increased if diffusion is reduced by e.g. increased membrane tortuosity (Kullmann et al 
1999). Conversely, reduction of transporter density or activity will reduce the steepness of the 
gradient and increase [Glu] at the cell surface. Reduced glutamate transport by loss or 
metabolic impairment is implicated in a broad range of neurodegenerative disorders including 
stroke (Rossi et al., 2000), traumatic brain injury (Goodrich et al., 2013), epilepsy (Coulter and 
Eid, 2012), Huntington's disease (Faideau et al., 2010), and ALS (Rothstein, 2009).  
 While a precise knowledge of the concentration of ambient glutamate in various brain 
regions in normal and neuropathological conditions is clearly desirable, reports of this value in 
the literature vary widely, with microdialysis approaches consistently providing estimates 
approximately two orders of magnitude greater than estimates based on electrophysiological 
measurement of tonic glutamate receptor activity. In the absence of transporter inhibition, 
ambient [Glu] has been reported as too low to activate AMPA receptors, even when 
desensitization is pharmacologically blocked (Le Meur et al., 2007). However, ambient [Glu] has 
been reported to tonically activate high-affinity NMDA receptors (Sah et al., 1989; Cavelier and 
Attwell, 2005; Le Meur et al., 2007, Herman and Jahr, 2007). Several patch clamp studies in 
acute hippocampal slice have provided estimates of ambient [Glu] based on analyses of the 
tonic NMDA receptor currents in CA1 pyramidal neurons. These have been reported as ~25 nM 
at 32°C (Herman and Jahr, 2007), 27-33 nM at 25°C and 77-89 nM at 35°C (Cavelier and 
Attwell, 2005), and 83-87 nM at 25°C (Le Meur et al., 2007). These estimates are not likely to be 
artifactually low due to loss of glutamate from the surface of the slice, because inclusion of 2 µM 
glutamate in the recording buffer did not alter the level of tonic receptor activity (Herman and 
Jahr 2007). The major source of glutamate in these studies was of non-vesicular origin. A range 
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of possible molecular mechanisms may underlie glutamate release, including glutamate-
permeable channels, the cystine-glutamate exchanger xCT, and passive membrane diffusion 
(Kimelberg et al., 1990; Baker et al., 2002; Cavelier and Attwell, 2005; for review see Cavelier et 
al., 2005). Elevation of ambient [Glu] by inhibition of glutamine synthetase suggests a major 
contribution of glutamate release from glia (Cavelier and Attwell, 2005, Le Meur et al., 2007). 
 The data and diffusion model presented here suggests that disrupted glutamate 
transport could underlie the important quantitative discrepancy between the low ambient 
glutamate estimates provided by the electrophysiological studies summarized above and those 
from numerous microdialysis studies which generally report ambient [Glu] values in the range of 
~2 µM (reviewed by Cavelier et al., 2005; Featherstone and Shippy, 2008). Histological 
analyses of tissue surrounding microdialysis probes provide evidence for a layer of damaged 
tissue surrounding the probe site (Clapp-Lilly, 1999; Bungay et al., 2003; Amina et al., 2003; 
Jaquins-Gerstl et al., 2009). We propose that disrupted transport in this region could lead to 
artifactually large concentrations in the probe volume. A critical assumption in our model is that 
the glutamate leak source is constant in a volume of metabolically damaged tissue where 
transport is impaired. The precise spatial changes in metabolic activity in a traumatized or 
ischemic region of tissue are unknown, but the assumption that glutamate release is constant is 
conservative. For example, glutamate release is increased by reversed glutamate transport due 
to impaired Na/K gradients during metabolic challenge (Rossi et al., 2000). We have simplified 
the spatial distribution of transporter impairment by assuming a Gaussian distribution, with 
sigma values as small as 100 µm leading to significant elevation of predicted probe [Glu] (Figure 
2.3).  
 Electrophysiological studies in slice have shown that blocking glutamate uptake leads to 
increased ambient [Glu] and activation of AMPA and NMDA receptors (Jabaudon et al., 1999, 
2000; Cavelier and Attwell, 2005; Le Meur et al., 2007, Herman and Jahr, 2007). Ischemia-
induced reversed transport also leads to large increases in extracellular [Glu] (Rossi et al., 
2000). Changes in [Glu] in response to physiological changes including drug exposure, 
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ischemia, and trauma have also been consistently reported using microdialysis approaches 
(Benveniste et al., 1984; Hagberg et al., 1985; Baker et al., 2002; Del Arco et al., 2003; Nyitrai 
et al., 2006). Such baseline changes are also predicted by changes in diffusion gradients 
surrounding a probe as a consequence of increases in glutamate release (Figure 2.3), 
suggesting that although the absolute value of extracellular [Glu] concentrations are 
overestimated in the probe dialysate volume, the changes in baseline probe [Glu] may 
accurately reflect approximately proportional increases in basal glutamate release.  
 Steady-state glutamate transport rates are considered to be well-approximated by 
Michaelis-Menten kinetics, but data presented here show that as transporter density increases, 
measured KM values can artifactually increase due to large diffusion gradients. If the ambient 
glutamate concentration in hippocampus is indeed as low as 25 nM (Herman and Jahr, 2007), 
then hippocampal transporters would be operating at rates approximately three orders of 
magnitude below their maximal steady-state capacity. This further highlights the importance of 
high transporter density, which has been reported in hippocampus to be approximately 104/µm2 
on astroglial membranes (Lehre and Danbolt, 1998). High transporter density facilitates 
maintenance of ambient glutamate concentrations far below KM values and additionally 
facilitates their buffering and transport action over the wide dynamic range encompassed by 
tonic and phasic glutamate signaling. 
!
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CHAPTER 3: SPECIFICITY AND ACTIONS OF AN ARYLASPARTATE INHIBITOR OF 
GLUTAMATE TRANSPORT AT THE SCHAFFER COLLATERAL-CA1 PYRAMIDAL CELL 
SYNAPSE!
Weinan Sun*, Katie M. Hoffman*, David C. Holley, and Michael P. Kavanaugh 
*these authors contributed equally to this work 
Abstract 
 In this study we characterized the pharmacological selectivity and physiological actions 
of a new arylaspartate glutamate transporter blocker, L-threo-ß-benzylaspartate (L-TBA). At 
concentrations up to 100 µM, L-TBA did not act as an AMPA receptor (AMPAR) or NMDA 
receptor (NMDAR) agonist or antagonist when applied to outside-out patches from mouse 
hippocampal CA1 pyramidal neurons. L-TBA had no effect on the amplitude of field excitatory 
postsynaptic potentials (fEPSPs) recorded at the Schaffer collateral-CA1 pyramidal cell 
synapse. Excitatory postsynaptic currents (EPSCs) in CA1 pyramidal neurons were unaffected 
by L-TBA in the presence of physiological extracellular Mg2+ concentrations, but in Mg2+-free 
solution, EPSCs were significantly prolonged as a consequence of increased NMDAR activity. 
Although L-TBA exhibited approximately four-fold selectivity for neuronal EAAT3 over glial 
EAAT1/EAAT2 transporter subtypes expressed in Xenopus oocytes, the L-TBA concentration-
dependence of the EPSC charge transfer increase in the absence of Mg2+ was the same in 
hippocampal slices from EAAT3 +/+ and EAAT3 -/- mice, suggesting that TBA effects were 
primarily due to block of glial transporters. Consistent with this, L-TBA blocked synaptically 
evoked transporter currents in CA1 astrocytes with a potency similar to its block of 
heterologously expressed glial transporters. Extracellular recording in the presence of 
physiological Mg2+ revealed that L-TBA prolonged fEPSPs in a frequency-dependent manner by 
selectively increasing the NMDAR-mediated component of the fEPSP during short bursts of 
activity. The data indicate that glial glutamate transporters play a dominant role in limiting 
extrasynaptic transmitter diffusion and binding to NMDARs. Furthermore, NMDAR signaling is 
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primarily limited by voltage-dependent Mg2+ block during low-frequency activity while the relative 
contribution of transport increases during short bursts of higher frequency signaling. 
!
Introduction  
 Five major subtypes of excitatory amino acid transporters exist in the CNS, and three of 
these (EAAT1-3; also known as GLAST, GLT-1, and EAAC1) are expressed in forebrain with 
distinct distribution patterns on astrocytes (EAAT1 and EAAT2) and neurons (EAAT3) (Furuta et 
al. 1997).  Studies utilizing glutamate uptake inhibitors broadly indicate that the transporters play 
key roles in glutamate homeostasis, and that they can in some cases shape receptor dynamics 
during synaptic transmission (Tzingounis & Wadiche 2007). While the synaptic effects of 
glutamate transport inhibition vary widely in different brain regions, studies at the hippocampal 
Schaffer collateral-CA1 pyramidal cell (SC-PC) synapse generally indicate that transporter 
activity does not strongly modify synaptic AMPAR responses [Isaacson & Nicoll, 1993; Sarantis 
et al. 1993; but see Tong & Jahr,1994; Tsukada et al., 2005]. In contrast, extrasynaptic NMDAR 
activity is enhanced by glutamate uptake block in this region (Asztely et al., 2007; Lozovaya et 
al., 1999; Diamond, 2001; Arnth-Jensen et al., 2002; Scimemi et al. 2009).   
  The relative contributions of the glial EAAT1 and EAAT2 and neuronal EAAT3 subtypes 
to restricting the spread of synaptically released glutamate from the SC-PC synapse is presently 
unclear. EAAT2 and EAAT3 are the dominant transporters in forebrain astrocytes and neurons, 
respectively, while EAAT1 is found on forebrain astrocytes at lower levels (Lehre & Danbolt, 
1998). The widely used glutamate uptake blocker DL-TBOA blocks EAAT2 and EAAT3-
mediated [3H]L-Glu uptake with IC50 values approximately seven-fold lower than for EAAT1 
(Shimamoto et al., 2000), and studies utilizing DL-TBOA indicate that it can induce spillover of 
synaptic glutamate onto NMDARs in hippocampus (Asztely et al., 2007; Lozovaya et al., 1999; 
Diamond, 2001; Arnth-Jensen et al., 2002; Scimemi et al. 2009). More selective inhibition of the 
postsynaptic neuronal transporter EAAT3 by intracellular ion substitution during whole cell 
recording or genetic manipulation also leads to augmentation of NMDAR-mediated EPSCs as 
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well as changes in synaptic plasticity (Diamond, 2001; Scimemi et al. 2009). In addition to 
uncertainty surrounding the detailed roles of individual EAAT subtypes in hippocampus, another 
issue concerns the general role of glutamate transport in restricting NMDAR signaling in the 
hippocampus under physiological conditions, since this effect has only been reported in 
conditions permissive for channel activity, i.e. voltage clamp of the postsynaptic neuron at 
positive potentials or in Mg2+-free ACSF (Asztely et al., 2007; Lozovaya et al., 1999; Diamond, 
2001; Arnth-Jensen et al., 2002; Scimemi et al. 2009).  
 Threo-ß-benzylaspartate (TBA) is a new arylaspartate derivative that is structurally 
related to TBOA, but with a shorter aryl linkage. In contrast to DL-TBOA, L-TBA displays 
moderate selectivity for the neuronal EAAT3 subtype over EAAT1 and EAAT2 (Esslinger et al., 
2005). In this work we show that L-TBA is highly selective for glutamate transporters over 
ionotropic glutamate receptors expressed on CA1 pyramidal cells and examined its effects on 
NMDAR activity during synaptic transmission at the Schaffer-CA1 synapse in wild-type and 
transgenic mice lacking the neuronal EAAT3 glutamate transporter to gain insights into the 
respective roles of glial and neuronal transporters. We also compared its actions on 
postsynaptic signaling using voltage clamp as well as extracellular recording to gain insights into 
the role of transporters in physiological conditions. The data suggest that glial transporters 
restrict synaptically released transmitter binding to NMDARs to a significantly greater extent 
than neuronal transporters. Further, voltage-dependent Mg2+ block plays a dominant role in 
limiting NMDAR signaling during low-frequency activity, while the relative influence of transport 
increases during short bursts of activity.  
!
Materials and Methods 
Drugs 
Drugs and chemicals were purchased from Sigma, except CNQX and DL-APV, which were from 
Tocris. L-TBA was synthesized and purified as described (Esslinger et al. 2005) and a stock 
solution was dissolved in DMSO at 50mM.  
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Hippocampal slice preparation and recording  
!
CD1 mice (P15-30) were anesthetized with isofluorane and decapitated in accordance with 
University of Montana IACUC regulations. The brain was rapidly dissected and placed in ice-
cold solution containing (in mM):  80 NaCl, 24 NaHCO3, 25 glucose, 75 sucrose, 2.5 KCl, 1.25 
NaH2PO4, 0.5 CaCl2,  5 MgCl2, 1 ascorbic acid, 3 Na pyruvate. The solution was saturated with 
95% O2 and 5% CO2 (pH 7.3). 300µm thick coronal hippocampal slices were cut using a 
vibratome (VT1200S Leica, Germany), then hemisected and placed in artificial cerebral spinal 
fluid (ACSF) containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11.4 
glucose, and 21.4 NaHCO3 saturated with 95%O2 and 5% CO2 (pH 7.3) and maintained at 
30°C. Slices were allowed at least 1 hour to recover before being placed in a submersion-type 
recording chamber perfused at 1.6-2.0 ml/minute with ACSF at 30°C. Slices were visualized on 
an upright fixed-stage microscope (Olympus BX51WI) equipped with IR-DIC optics. The 
recording pipettes (3-6MΩ resistance) were filled with internal solution containing (in mM): 110 
Cs methanesulfonate, 38 CsCl, 10 HEPES, 10 Na-phosphocreatine, 0.1 EGTA, 0.3 Mg-ATP, 0.3 
GTP, 5 QX-314, pH=7.3. Series resistance (typically 15-20 MOhm), was monitored and 
recording was terminated if a change >20% was observed. Holding potential was -60 to -70 mV. 
100µM picrotoxin was added to the ACSF for whole-cell recordings and an incision was made 
between CA3 and CA1. Extracellular field excitatory post synaptic potentials (fEPSPs) were 
recorded using glass electrodes filled with ACSF. EPSCs and fEPSPs were induced with 100 µs 
current pulses between 0.1mA - 0.4mA administered through ACSF-filled stimulating pipettes 
placed in stratum radiatum. Recordings were made with analog-digital converters and amplifiers 
from Molecular Devices, and data were acquired at 20kHz and filtered at 5-10 kHz. Data were 
acquired and analyzed with Axograph software (version 1.1.6). EPSC charge transfer changes 
and fEPSP prolongation were quantified by integrating the area from the normalized peak of the 
response until 100 ms after the peak. EPSCs and fEPSPs were elicited with alternating single 
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and paired stimuli at varying intervals, and the response time-integral of the second response 
was calculated following subtraction of the first. Data are presented as mean ± S.E. and were 
evaluated by Student's paired t-test or as noted. Nucleated patches were pulled from the soma 
of CA1 pyramidal neurons of CD1 mice (P10-20) identified under transmitted IR-DIC optics. 
Intracellular pipette solution contained (in mM): 60 Cs-methanesulfonate, 38 CsCl, 20 
Cs4BAPTA (4*CsOH+BAPTA), 10 HEPES, 10 Na-phosphocreatine, 4 MgATP, and 0.3 NaGTP, 5 
QX-314, pH 7.3 (adjusted by HCl or CsOH). Patch recordings were made at 25° in the presence 
of 20 µM CNQX. L-glutamate (1 mM) was applied for 50ms or 200ms through a 200 µm 
diameter double-barreled theta tube attached to a piezoelectric bimorph. Solution exchange 
kinetics were estimated following patch rupture by measuring junction currents during switches 
between iso- and hypo-osmotic solutions as displayed above receptor current records.  
!
Results  
!
Computational docking of TBA with glutamate transporters 
!
We constructed an EAAT3 model using published homologous archaeal GltPh structures 
(Boudker et al., 2007, Yernool et al., 2004) and docked aryl-aspartate analogs in order to 
identify and compare plausible structural interactions. A single Na+ ion was positioned in the 
structure according to the structural determination of a Tl+ ion in the GltPh/L-3-Br-TBOA complex 
(Boudker et al., 2007) and corresponding to electrostatic predictions of Na+ ion binding sites in 
EAAT3 (Holley & Kavanaugh, 2009). The EAAT3 residues R447 and D444 interact with the γ-
carboxylate and the α-amino group of transported glutamate and determine substrate specificity 
(Bendahan et al., 2000; Teichman & Kanner, 2007). The computationally docked L-TBA complex 
suggested corresponding electrostatic interactions between the blocker carboxyl and amino 
groups with the R447 and D444 residues in EAAT3 (Figure 3.1A). The most energetically 
favorable L-TBA complexes corresponded to the benzyl group orientation of L-3-Br-TBOA that 
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was determined in the GltPh crystal structure, with interactions between the ring and non-polar 
residues near the tip of HP2. Interestingly, when computational docking of L-TBOA was 
performed, an energetically favorable conformation was observed that involved an interaction of 
R447 with the ether group of the blocker. This alternate orientation positions the benzyl group in 
an ‘up’ conformation perpendicular to the membrane and parallel to TMD7, and aligns it with 
non-polar residues in TM7, TM8 and HP2 (Figure 3.1B). Docking energies (Table 1) predict that 
L-3-Br-TBOA could orient in either conformation while L-TBOA is predicted to predominantly 
align in the perpendicular, ‘up’ orientation, and L-TBA aligns predominantly in the ‘down’ 
conformation parallel to the membrane plane.  
!
!
"  
Figure 3.1. Interaction of L-TBA with EAATs. (A) Docking of L-TBA (green) and L-TBOA 
(gray) in EAAT3 model showing overlap of functional groups interacting with R447 and D444, 
with benzyl groups oriented toward extracellular loop HP2 as seen in (Esslinger et al., 2005). (B) 
Surface depiction of the transporter binding site (hydrophobic regions blue) showing L-TBA and 
alternate docking orientation of L-TBOA with benzyl ring aligned in alternate hydrophobic 
pocket. 
!
!
!
!
!
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Interaction of L-TBA with glutamate transporters  
!
L-TBA inhibits uptake mediated by heterologously expressed EAATs, with preference for the 
neuronal glutamate transporter subtype EAAT3 (Esslinger et al. 2005). However, transport 
currents mediated by the major glial subtypes are also blocked in Xenopus oocytes expressing 
the transporters (Figure 3.2A,B). To examine the actions of L-TBA on glial transporters in situ, 
synaptically activated transport currents (STCs) were recorded in astrocytes in stratum radiatum 
of area CA1 in mouse hippocampal slices. Currents evoked by stimulation in the presence of 
ionotropic blockers CNQX (20 µM) and DL-APV (50 µM) revealed a current with properties 
consistent with glial transporters EAAT1 and EAAT2 together with a slowly decaying potassium 
current as previously described (Bergles & Jahr, 1997). The STC, or transporter-mediated 
component of the evoked current, peaked and decayed within approximately 20 ms (Figure 
3.2C2). The peak STC was blocked 67±10% by 30 µM L-TBA (n=4; Figure 3.2C).  
!
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Figure 3.2. Effects of L-TBA on native and recombinant transporters. (A) Effect of 30µM L-
TBA on synaptically activated transport current (STC) in hippocampal CA1 astrocyte. (A1) 
Currents in the presence or absence of L-TBA were evoked by stimulation in stratum radiatum 
in the continuous presence of ionotropic receptor antagonists (see methods). (A2) Subtracted 
current (control - L-TBA). 30µM L-TBOA blocked 66.7±10.4 of the peak STC (n=4). (B) 
Representative recording from voltage-clamped Xenopus oocyte expressing astrocyte 
transporter subtype EAAT2. 100 µM L-TBA partially blocks equimolar L-Glu uptake current 
mediated by EAAT2. (C) Summary of L-TBA concentration-dependence of block of 100 µM L-
Glu currents in oocytes expressing EAAT1-3, showing approximately four-fold selectivity for 
EAAT3 by least-squares minimized fits to mean data generating IC50 values of 56, 52, and 13 
µM, respectively. !
Effects of TBA on fast excitatory synaptic transmission 
!
  Because the potential actions of L-TBA on ionotropic glutamate receptors have not been 
examined, its functional effects on receptor currents recorded in outside-out patches from CA1 
pyramidal neurons were first evaluated. Fast application of 100 µM L- Glu alone induced robust 
AMPAR and NMDAR currents, while application of 100 µM L-TBA alone failed to induce 
measurable currents (Figure 3.3).  Co-application of 100 µM L-TBA showed no antagonism of 
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the AMPAR (101.2±2.0% of control; n=4; p>0.6) or NMDAR currents (98.7±2.3% of control; n=5, 
p=0.59; Fig. 3.3C) induced by 100 µM L-Glu. 
 The amplitude of fEPSPs elicited by .05 Hz stimulation in stratum radiatum was not 
affected by application of 30 µM L-TBA (100±3% of control; n=41 slices). There was also no 
significant change in the 50 ms paired-pulse facilitation of the peak amplitude of fEPSPs 
induced by L-TBA (control, 1.72±.03; TBA, 1.60±.08; p>.05). In whole cell voltage clamp 
recordings from CA1 pyramidal neurons, the effect of L-TBA on EPSC kinetics was highly 
[Mg2+]-dependent (Figure 3.4). 
!
"  
Figure 3.3. Representative recordings from outside-out patches excised from CA1 
pyramidal neurons illustrating AMPAR and NMDAR responses to rapid application of 100 
µM L-glutamate and/or 100µM L-TBA for durations indicated by solution exchange traces 
above. Responses at -60mV showing lack of agonist or antagonist actions of L-TBA on 
AMPARs (A; with 1.2 mM Mg2+) and NMDARs (B; with 0 mM Mg2+/20µM glycine/20µM CNQX). 
Scale bars are 50/200 ms and 50/100 pA for AMPAR/NMDAR responses respectively. (C) 
Summary of mean effects of 100µM L-TBA on 100µM L-Glu AMPAR and NMDAR responses. !
!
!
!
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Figure 3.4. Actions of L-TBA (30 µM) on postsynaptic responses at the CA1 Schaffer 
collateral-pyramidal neuron synapse of EAAT3 +/+ (A) and EAAT3 -/- (B) mice. 
Representative whole cell recordings (-60 mV) showing effect of L-TBA on EPSCs evoked by 
stimulation in stratum radiatum in the presence (A1, B1) and absence (A2, B2) of physiological 
extracellular Mg2+ (1.2 mM). (C) Summary of data showing EPSC charge transfer increase in 
slices from EAAT3 (+/+) and (-/-) mice by 30 µM L-TBA in the absence and presence of Mg2+ 
(n=5-7 slices; p<0.05). (D) Summary of data showing statistically identical L-TBA concentration-
dependence of EPSC charge transfer increase (normalized to control) for EAAT3 +/+ (open 
squares) and EAAT3 -/- (filled squares) (n=4). 
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In Mg2+-free ACSF, 30 µM L-TBA significantly prolonged evoked EPSCs. The charge transfer in 
the presence of L-TBA was 141±6% of that without drug (n=6; p<.05), with no significant effect 
on the peak amplitude (102±7% of control, n=6). The effect of L-TBA on EPSC kinetics was 
presumed to be mediated by NMDAR activity, because in the presence of physiological (1.2 
mM) Mg2+, 30 µM TBA had no effect on the time course of the EPSC (charge transfer 101±3%; 
p=.78, n=4; Fig.4A1). The prolongation was also not seen in the presence of 50 µM DL-APV in 
the absence of Mg2+ (data not shown). The effects of L-TBA on the EPSC charge transfer were 
concentration-dependent and not statistically different for EAAT3 (+/+) and EAAT3 (-/-) mice 
(Figure 3.4C,D). 
 Extracellular recording in the presence of physiological (1.2 mM) Mg2+ revealed an effect 
of L-TBA on fEPSP kinetics that exhibited pronounced frequency-dependence. 30 µM L-TBA 
slightly prolonged fEPSPs elicited by low-frequency (.05Hz) stimulation, while time-integrals of 
fEPSPs recorded during a brief 20Hz burst prolonged the time course of the fEPSP significantly 
further (Figure 5; 31±7% vs 69±21% for the first and second fEPSPs, respectively, n=9, p=.02). 
Increasing stimulus strength to increase the fEPSP magnitude by an amount comparable to the 
frequency facilitation had no effect on the time course of the fEPSP (data not shown). The L-
TBA-induced prolongation at both low and high frequencies was not observed in the presence 
of 50 µM APV (Figure 3.5).   
 44
"  
Figure 3.5. Actions of L-TBA on field responses at the CA1 Schaffer collateral-pyramidal 
neuron synapse. (A) Representative field EPSPs elicited in response to three stimuli delivered 
at 20 Hz in stratum radiatum. 30 µM L-TBA (black trace) prolonged fEPSPs relative to control 
(gray trace) in an activity-dependent manner (p=0.02). The TBA prolongation was inhibited by 
co-application of 50µM DL-APV (2nd black trace). (B) Summary of effects on fEPSP time-
integrals elicited by 1, 2 and 3 stimuli normalized to corresponding fEPSPs in control ACSF 
(*p<.05 paired t-test; n=9 slices for one and two stimuli, n=5 slices for three stimuli). !
Discussion 
                                                                                                                                                          
Selective glutamate uptake blockers are critical tools for studying the roles of glutamate 
transporters in modulating synaptic activity (Asztely et al., 2007; Lozovaya et al., 1999; 
Diamond, 2001; Arnth-Jensen et al., 2002; Scimemi et al. 2009). Both the widely used DL-TBOA 
and the newer analog characterized in this study are ß-substituted aryl aspartate analogs. The 
data presented demonstrate that L-TBA is selective for glutamate transporters over ionotropic 
glutamate receptors expressed on pyramidal neurons, as it neither antagonized ionotropic 
receptor responses to equimolar glutamate nor activated responses at concentrations up to 
100µM. Unlike TBOA, TBA lacks an ether linkage between the aryl group and the amino acid, 
resulting in a slight change in distance and bond angle of the benzyl ring relative to the aspartyl 
group (Figure 2A). The computationally predicted docking orientation of L-TBA was similar to 
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the reported structure of L-3-Br-TBOA complexed with the archaeal homolog GltPh (Boudker et 
al., 2007), with key electrostatic interactions involving R447 and D444 in TMD7 of EAAT3. 
Predicted interactions of the benzyl group with hydrophobic regions of EAAT3 were also in 
agreement with the structure of L-3-Br-TBOA complexed with GltPh. In this conformation, the 
blocker prevents closure of the extracellular-facing HP2 loop which normally occludes bound L-
aspartate (Yernool et al. 2004). Interestingly, a distinct orientation was predicted for L-TBOA 
because of the alternate interaction of R447 with the ether oxygen of L-TBOA. This interaction 
preserves the α-amino group interaction with D444 but causes the benzyl group to rotate to an 
orientation perpendicular to the membrane plane, fitting into a hydrophobic domain bordered by 
TMDs 7/8 and HP2 (Figure 3.2B). These predicted conformations suggest that the HP2 loop 
position in the L-TBA and L-TBOA transporter complexes may slightly differ. In terms of 
transporter selectivity, L-TBOA and L-TBA exhibit moderate selectivity for the the glial EAAT2 
and neuronal EAAT3 subtypes, respectively (Shimamoto et al., 2000; Esslinger et al., 2005). 
While L-TBA and DL-TBOA differ in subtype selectivity, each exhibits significant subtype cross-
reactivity at concentrations typically used. Because the effects of L-TBA on EPSC and fEPSP 
kinetics observed in this study were not significantly different in wild-type and transgenic mice 
lacking the EAAT3 gene, we conclude that they were primarily mediated by inhibition of glial 
transporters EAAT1 and/or EAAT2, which would be predicted to be approximately 75% occupied 
at the inhibitor concentration used (30µM) based on the KD values of 12 µM and 9 µM for 
EAAT1 and EAAT2, respectively. This prediction is consistent with the 67±10% observed block 
of the peak synaptic transporter currents in astrocytes by L-TBA. While the glial transporter-
dependent effects of L-TBA in increasing synaptic glutamate reaching NMDARs appear to 
dominate the results we observed, it is important to note that the selective loss of neuronal 
transport has been reported to result in changes in both synaptic transmission and plasticity that 
were not addressed here (Diamond, 2001; Scimemi et al., 2009).  
 Past work has generally examined transporter control of extrasynaptic glutamate 
spillover onto NMDARs under voltage clamp by examining the effect of transporter block on 
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EPSCs elicited under conditions where NMDAR activity is enabled (i.e. depolarized potentials or 
Mg2+-free solution). Consistent with work from several groups (Asztely et al., 2007; Lozovaya et 
al., 1999; Diamond, 2001; Arnth-Jensen et al., 2002; Scimemi et al. 2009), we found that EAAT 
inhibition significantly prolonged EPSCs recorded at the Schaffer-CA1 pyramidal cell synapse in 
Mg2+-free conditions due to enhanced NMDAR signaling. L-TBA had no effect on postsynaptic 
responses in voltage clamp conditions with NMDARs blocked by physiological [Mg2+]. Because 
voltage-dependent Mg2+ block of NMDARs is dynamic during synaptic transmission, gaining 
greater insight into the role of glutamate transport in modulating synaptic activity will require the 
use of selective transport blockers in physiological conditions without voltage clamp. In this 
study we have begun to address this issue and have shown that NMDAR-mediated components 
of fEPSPs can be isolated that are dependent on glutamate transporter activity in a frequency-
dependent manner. The effect of L-TBA on the kinetics of fEPSPs elicited by low-frequency 
stimulation in physiological Mg2+ was increased during brief bursts of higher frequency synaptic 
activity, and this prolongation was blocked by the NMDAR antagonist APV. This effect was not 
likely to be due simply to frequency-facilitation of transmitter release, because increasing 
stimulus strength did not affect the kinetics of fEPSPs elicited by low frequency stimulation. The 
data suggest that the influence of glial glutamate transporters on NMDAR signaling are likely to 
vary with synaptic frequency through postsynaptic voltage responses. A deeper quantitative 
understanding of the role of glutamate transporters in excitatory synaptic transmission will 
require further studies accounting for these variables. 
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CHAPTER 4 :EFFECTS OF SYNAPTIC FREQUENCY AND GLUTAMATE TRANSPORT ON 
NMDA RECEPTOR ACTIVITY AT THE SCHAFFER-CA1 SYNAPSE  !
Weinan Sun*, Katie M. Hoffman*, and Michael P. Kavanaugh 
*these authors contributed equally to this work 
!
 Glutamate transporters are thought to help maintain synapse specificity by limiting 
spillover of glutamate. In the CA1 region of hippocampus, inhibition of glutamate transport has 
been shown to cause increased NMDAR activation in conditions preventing voltage-dependent 
Mg2+ block, but the roles of glutamate transport during normal synaptic transmission are less 
well understood. In this work we find that similar to inhibiting transport in the absence of Mg2+, 
increasing release site density prolongs the time course of EPSCs and fEPSPs by increasing 
NMDAR activation. These effects are not seen during low frequency activity in the presence of 
physiological extracellular Mg2+ concentrations. In normal physiological conditions, the NMDAR 
component of the fEPSP is selectively enhanced by brief bursts of activity through a mechanism 
distinct from presynaptic facilitation of transmitter release. The frequency-dependence of the 
NMDAR facilitation matches the decay kinetics of Mg2+-blocked NMDAR channels in patches 
from CA1 pyramidal neurons monitored with depolarizing voltage pulses. Inhibition of glutamate 
transport increased the amplitude and prolonged the interpulse interval-dependence of the the 
NMDAR-selective frequency facilitation. The data suggest that at low frequencies, Mg2+ block 
rather than glutamate transport plays a dominant role in restricting extrasynaptic NMDAR 
activity, but that a pool of glutamate-bound and Mg2+-blocked NMDARs can signal in a phase-
shifted manner during repetitive synaptic activity at frequencies governed by channel kinetics 
and glutamate transport. 
  
Introduction  
 Glutamate is the primary excitatory neurotransmitter in the CNS, and following synaptic 
release it diffuses and binds to a variety of ligand-gated ion channels and G-protein coupled 
receptors with differing affinities and spatial distributions. In addition to these targets, 
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synaptically released glutamate also interacts with glutamate transporters as it diffuses through 
the extracellular space. Five major subtypes of excitatory amino acid transporters exist in the 
CNS, and three of these (EAAT1-3; also known as GLAST, GLT1, and EAAC1) are expressed in 
forebrain with primary distribution patterns on astrocytes (EAAT1/2) and neurons (EAAT3), 
respectively (Furuta et al. 1997). Studies with glutamate transporter blockers indicate that the 
transporters play key roles in controlling glutamate homeostasis in the CNS and in some 
synapses transporters modulate the dynamics of fast ionotropic glutamate receptor signaling 
during synaptic transmission (Marcaggi and Attwell, 2004; Tzingounis and Wadiche, 2007). A 
general consensus from work at the hippocampal Shaffer-CA1 pyramidal synapse is that 
transporter activity does not acutely modify synaptic AMPAR signaling (Isaacson and Nicoll, 
1993; Sarantis et al., 1993). However, voltage-clamp recordings of NMDAR EPSCs indicate that 
inhibition of glutamate transport can lead to spillover and activation of extrasynaptic NMDARs 
(Asztely et al., 1997; Lozovaya et al., 1999; Diamond, 2001, Arnth-Jensen et al. 2002; Tsukada 
et al., 2005; Scimemi et al., 2009).  
 A notable limitation of studies examining the influence of glutamate transport on 
postsynaptic NMDAR currents arises from the necessity of recording these currents in non-
physiological voltage-clamp and/or Mg2+-free conditions due to voltage-dependent block of the 
channels by Mg2+ (Mayer et al. 1984; Nowak et al. 1984). Previous work has shown that 
synaptic NMDAR signaling is likely to be strongly influenced by Mg2+ block and the temporal 
pattern of postsynaptic voltage changes (Collingridge et al., 1988). In this work we examined the 
influence of glutamate transport and postsynaptic activity on excitatory signaling in CA1 
pyramidal neurons by recording responses in the presence and absence of extracellular Mg2+. 
We used the selective glutamate transporter inhibitor L-threo-beta-benzylaspartate (L-TBA; 
Esslinger et al. 2005; Sun et al, 2011) to confirm the role of transport in restricting glutamate 
diffusion and binding to extrasynaptic NMDARs. In order to study the influence of transport in 
physiologically relevant conditions with extracellular Mg2+, we examined the effects of L-TBA on 
the isolated AMPAR- and NMDAR-mediated components of extracellular fEPSPs. At low 
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frequencies of synaptic activity, glutamate transport inhibition had minimal impact on synaptic 
signaling, but with higher frequencies of stimulation NMDAR signaling was facilitated due to 
relief of Mg2+ block from glutamate-occupied receptors, and this effect was significantly 
enhanced by inhibition of glutamate transport. The data suggest that synaptic NMDAR 
responses are controlled by interacting factors including release frequency, glutamate transport, 
Mg2+ block, and NMDAR channel kinetics. In physiological conditions with transport intact, the 
threshold frequency for selective NMDAR signaling corresponds approximately to theta rhythm, 
which is correlated with induction of LTP. 
!
Materials and Methods 
!
Drugs 
!
Drugs and chemicals were purchased from Sigma, except CNQX and DL-APV, which were from 
Tocris. L-TBA was synthesized and purified as described (Esslinger et al. 2005) and a stock 
solution was dissolved in DMSO at 50mM.  
!
Hippocampal slice preparation and recording  
!
CD1 mice (P15-30) were anesthetized with isofluorane and decapitated in accordance with 
University of Montana IACUC regulations. The brain was rapidly dissected and placed in ice-
cold solution containing (in mM):  80 NaCl, 24 NaHCO3, 25 glucose, 75 sucrose, 2.5 KCl, 1.25 
NaH2PO4, 0.5 CaCl2,  5 MgCl2, 1 ascorbic acid, 3 Na pyruvate. The solution was saturated with 
95% O2 and 5% CO2 (pH 7.3). 300µm thick coronal hippocampal slices were cut using a 
vibratome (VT1200S Leica, Germany), then hemisected and placed in artificial cerebral spinal 
fluid (ACSF) containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 11.4 
glucose, and 21.4 NaHCO3 saturated with 95%O2 and 5% CO2 (pH 7.3) and maintained at 
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30°C. Slices were allowed at least 1 hour to recover before being placed in a submersion-type 
recording chamber perfused at 1.6-2.0 ml/minute with ACSF at 30°C. Slices were visualized on 
an upright fixed-stage microscope (Olympus BX51WI) equipped with IR-DIC optics. The 
recording pipettes (3-6MΩ resistance) were filled with internal solution containing (in mM): 110 
Cs methanesulfonate, 38 CsCl, 10 HEPES, 10 Na-phosphocreatine, 0.1 EGTA, 0.3 Mg-ATP, 0.3 
GTP, 5 QX-314, pH=7.3. Series resistance (typically 15-20 MOhm), was monitored and 
recording was terminated if a change >20% was observed. Holding potential was -60 to -70 mV. 
100µM picrotoxin was added to the ACSF for whole-cell recordings and an incision was made 
between CA3 and CA1. Extracellular field excitatory post synaptic potentials (fEPSPs) were 
recorded using glass electrodes filled with ACSF. EPSCs and fEPSPs were induced with 100 µs 
current pulses between 0.1mA - 0.4mA administered through ACSF-filled stimulating pipettes 
placed in stratum radiatum. Recordings were made with analog-digital converters and amplifiers 
from Molecular Devices, and data were acquired at 20kHz and filtered at 5-10 kHz. Data were 
acquired and analyzed with Axograph software (version 1.1.6). EPSC charge transfer changes 
and fEPSP prolongation were quantified by integrating the area from the normalized peak of the 
response until 100 ms after the peak. EPSCs and fEPSPs were elicited with alternating single 
and paired stimuli at varying intervals, and the response time-integral of the second response 
was calculated following subtraction of the first. Data are presented as mean ± S.E. and were 
evaluated by Student's paired t-test or as noted. 
!
Nucleated outside-out patch recordings 
!
Nucleated patches were pulled from the soma of CA1 pyramidal neurons of CD1 mice (P10-12) 
identified under transmitted IR-DIC optics. Intracellular pipette solution contained (in mM): 60 
Cs-methanesulfonate, 38 CsCl, 20 Cs4BAPTA (4*CsOH+BAPTA), 10 HEPES, 10 Na-
phosphocreatine, 4 MgATP, and 0.3 NaGTP, 5 QX-314, pH 7.3 (adjusted by HCl or CsOH). 
Patch recordings were made at 25°C in the presence of 20 µM CNQX. L-glutamate (1 mM) was 
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applied for 1 ms through a 200 µm diameter double-barreled theta tube attached to a 
piezoelectric bimorph. Solution exchange kinetics were estimated following patch rupture by 
measuring junction currents during switches between iso- and hypo-osmotic solutions as 
displayed above receptor current records. To investigate the kinetics of Mg2+- blocked channels, 
5 ms voltage pulses from -60mV to -20mV or +40mV were applied at varying intervals as 
indicated following the glutamate pulse. NMDAR currents were also recorded at -60 mV in Mg2+-
free ACSF containing 20 µM CNQX and 20 µM glycine. Control voltage jump recordings without 
a glutamate pulse were made to subtract leak and capacitance currents. Averages of 5-10 
responses to repetitive application are shown.  
!
Results 
Mg2+ and transport modulation of EPSCs during enhanced glutamate release 
!
 NMDAR-mediated EPSCs at the Schaffer-CA1 pyramidal cell synapse are enhanced by 
spillover when glutamate transport is inhibited or when glutamate release is increased (Asztely 
et al., 1997; Lozovaya et al., 1999, 2004; Diamond, 2001, Arnth-Jensen et al. 2002; Tsukada et 
al., 2005; Scimemi et al., 2004, 2009; Sun et al., 2011). We examined the interacting influences 
of Mg2+, frequency facilitation, and glutamate transport on EPSC kinetics. Paired-pulse 
stimulation (50 ms interpulse interval) facilitated the EPSC amplitude to 187 ±  10% and 185 ± 
11% of the first EPSC in the presence and absence of Mg2+, respectively (n=14). After 
normalizing peak amplitudes, control and facilitated EPSCs recorded in the presence of 1.2 mM 
Mg2+ were superimposable and the normalized charge transfer in the second EPSC was 98.9 ± 
1.9% of that in the first (n=14; figure 4.1). As expected from relief of voltage-dependent Mg2+ 
NMDAR block (Nowak et al. 1984; Mayer et al. 1984), removal of Mg2+ prolonged EPSCs 
elicited by single stimuli (normalized charge transfer increased to 137 ± 6% of control; p=0.006; 
n=4) and this prolongation was significantly greater (p<0.02) in the facilitated EPSC (normalized 
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charge transfer 212 ± 22% of control; p=0.015 n=4; figure 4.1). The prolongation of the first and 
second EPSC after removal of Mg2+ was due solely to relief of block of the NMDAR response 
without affecting AMPAR signaling, as the prolongation in Mg2+-free ACSF was completely 
blocked by 50 µM DL-APV (figure 4.1). 
 In order to examine the involvement of glutamate transport in the low frequency and 
frequency-facilitated NMDAR responses, we used the glutamate transporter blocker L-threo-
benzylaspartate (L-TBA), an aspartate derivative with high selectivity for glutamate transporters 
over ionotropic glutamate receptors (Esslinger et al., 2007; Sun et al. 2011). At 30 µM, a 
concentration that blocks approximately 67% of the astroglial synaptic transport current in CA1 
(Sun et al. 2011), L-TBA had no effect on either the control or facilitated EPSC in the presence 
of 1.2 mM Mg2+ (charge transfer 101.1±3.3% and 101.4±11.8% of control, respectively; n=4, 
figure 4.1). In the absence of Mg2+, L-TBA prolonged both the first and second EPSCs induced 
by paired pulse stimulation (charge transfers increased to 141 ± 6.3% and 163 ± 9% of control, 
respectively; n=6; P<0.01; figure 4.1). The mean prolongation induced by L-TBA was greater in 
the facilitated EPSC, but this difference did not reach statistical significance (p=0.08). !
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Figure 4.1. EPSC prolongation caused by transport block and/or increased release site 
density. (A) EPSC induced by a paired pulse stimulation in the presence or absence of 30µM 
TBA in ACSF containing 1.2mM Mg2+ (A1) or 0 Mg2+ (A2), the charge transfer of 1st and 2nd 
EPSC after TBA were 141.4±6.3% (B2, n=6, p<0.01) and 162.7±8.9% (n=6, p<0.0001) of control 
for 0 Mg2+ group, 101.1±3.3% (B2, n=4, p>0.7) and 101.4±11.8% (n=4, p>0.9) for 1.2mM Mg2+ 
group. TBA prolongation of 1st EPSC and 2nd EPSC in 0 Mg2+  solution are not significantly 
different (p=.08, A3). (B1) Normalized 1st and 2nd EPSC induced by a paired pulse stimulation 
with 50ms interpulse interval in control ACSF (containing 1.2mM Mg2+) and in 0 Mg2+ ACSF. 
(B3) Quantification of Mg2+ removal’s effect on EPSC’s time integral with presence or absence of 
APV. 
Mg2+ and transport modulation of field responses to enhanced glutamate release 
 The above results are consistent with a number of studies indicating that facilitated 
glutamate release results in a significant increase in transmitter binding to NMDARs and that 
this binding is limited by transporter activity (Asztely et al., 1997; Lozovaya et al., 1999, 2004; 
Diamond, 2001, Arnth-Jensen et al. 2002; Tsukada et al., 2005; Scimemi et al., 2004, 2009; Sun 
et al., 2011). In addition to transport, another limiting factor in the NMDAR response is the 
degree of voltage-dependent Mg2+ block, which is dynamically controlled during synaptic 
transmission under physiological conditions. To investigate the role of Mg2+ in controlling 
activation of NMDARs by glutamate spillover in the absence of voltage clamp, we utilized 
extracellular field recording and isolated AMPAR and NMDAR contributions to fEPSPs in order 
to monitor the change in each as release site density and transporter activity varied. We verified 
that NMDAR fEPSPs could be detected by evoking responses in the presence of CNQX (10µM) 
and in the absence of Mg2+. The remaining field response in these conditions was blocked by 
DL-APV (50µM), confirming that it was NMDAR-mediated (figure 4.2). In comparison with the 
fEPSP kinetics in physiological ACSF, the NMDAR fEPSPs isolated in the absence of Mg2+ 
displayed slower kinetics, as expected from the difference in channel kinetics and glutamate 
affinity between NMDARs and AMPARs (Spruston et al., 1995; Figure 2;  10-90% rise time 1.67 
± 0.15 ms n=11, 6.29 ± 0.66 ms; n=11; p<.0001). In comparison to the fEPSPs recorded in 
physiological Mg2+, which predominantly reflect AMPAR activity, the kinetics of NMDAR fEPSPs 
isolated in the nominal absence of Mg2+ displayed a marked sensitivity to release site density 
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and decayed more slowly as stimulus strength was increased (figure 4.2). The normalized time-
integrals of the fEPSPs in control ACSF were constant over a range of stimulus strengths, while 
the NMDAR fEPSP decay times increased monotonically over the same range (Figure 4.2C).  
!
!
Figure 4.2. Isolated NMDAR fEPSPs at the CA3-CA1 pyramidal neuron synapse display 
slower decay kinetics with increasing release site density. (A1) Bath application of 0 Mg2+ 
ACSF and 10µM CNQX isolate a NMDAR-mediated fEPSP confirmed by complete block with 
the  NMDAR antagonist DL-APV (50µM), representative trace. (A2) The normalized Mg2+/10µM 
CNQX (NMDAR) fEPSP rise time is slowed and decay kinetics are prolonged as compared to 
the fEPSP in control ACSF (1.2mM Mg2+, representative trace.) (B) upper trace: NMDAR (0 
Mg2+/10µM CNQX) fEPSP decay kinetics are prolonged by stimulation strength increase (from 
20% to 80% of the intensity which induces pop. spike). Lower trace: Stimulation strength does 
not alter AMPAR/NMDAR fEPSP kinetics elicited at low frequency in the presence of Mg2+. (C) 
Normalized fEPSP time-integral (peak to 200ms after the peak) of individual experiments in 
control (n=44 from 17 slices) and 0 Mg2+/10µM CNQX (n=33 from 13 slices) conditions as a 
function of the first fEPSP amplitude and were modeled by linear regression. (The normalized 
time-integrals of the control fEPSPs were constant over a range of stimulus strengths r=0.076, 
Slope was not significantly greater than 0, p=0.65, while the NMDAR fEPSP decay times 
increased over the same range (Figure 2B) r=0.482, Slope was significantly greater than 0, 
p=0.004.)   
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Figure 4.3. The enhancement of NMDAR activation induced by transport block is 
frequency-dependent manner in physiological (non-voltage clamp, 1.2 mM Mg2+) 
conditions. (A) 50 µM DL-APV revealed an APV sensitive component in fEPSP.   (B) 30 µM L-
TBA prolonged fEPSPs in a frequency-dependent manner that was reversed by co-application 
of 50µM DL-APV. ((C) Summary of mean effects in 50µM DL-APV(n=44, 9 slices), 30µM TBA 
(n=42, 9 slices) and 50µM DL-APV and 30µM TBA (n=9, 9 slices) in a single and paired-pulse 
protocol; * denotes p<.05. (D, E) Field EPSP time-integral of Individual experiments (all peaks 
were normalized to 1, integrated from 0-200ms after peak) in control and 30µM TBA as a 
function of first (D) and second (E) fEPSP amplitude (n=43). (least-squares linear regression/
slope analysis L-TBA: r =.43, p=0.004; control: r = 0.076, p=0.650)  !
!
 We next sought to characterize NMDAR synaptic responses in physiological conditions 
by isolating their contribution to the field response with 50 µM DL-APV in ACSF containing 
1.2mM Mg2+. In these conditions, the primary component of the Schaffer-CA1 fEPSP arises 
from AMPAR signaling, but 50 µM DL-APV revealed an NMDAR-mediated component of the 
fEPSP detectable by an increased rate of decay in its presence (figure 4.3). The change in the 
fEPSP kinetics induced by DL-APV was quantified by measuring the time integrals of the 
responses after normalizing the peak amplitudes. The NMDAR-mediated field signal was 
selectively enhanced relative to the AMPAR signal by paired-pulse facilitation. The normalized 
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peak time integrals of the first and second fEPSPs in the presence of DL-APV were 90 ± 2 and 
81 ± 2% of control, respectively (p<0.01; n=44; figure 4.3). 
 Inhibition of glutamate transport by 30µM L-TBA slowed the fEPSP decay kinetics, and 
this effect was significantly greater in the frequency-facilitated fEPSP relative to the response 
elicited at low frequency (p=.001; Figure 4.3B,C). The effect of TBA on the fEPSP kinetics was 
reversed by DL-APV, suggesting that the prolongation associated with transporter inhibition was 
predominately mediated by NMDARs. DL-APV did not speed the frequency-facilitated fEPSP 
decay kinetics to the extent seen in the absence of L-TBA, suggesting that L-TBA may have a 
small additional effect on the kinetics of the AMPAR signal (figure 4.3B,C).  
 The selective increase in paired-pulse facilitation of NMDAR signaling caused by 
glutamate transporter inhibition could potentially involve several factors, including an increase in 
overall release site density due to increased presynaptic release probability (Dobrunz and 
Stevens, 1997), increasing multivesicular release from a subset of individual synapses (Christie 
and Jahr, 2006), and/or by overwhelming glutamate transport (Diamond and Jahr, 2000). To 
examine the effect of increased release site density, stimulus strength was varied in the 
presence or absence of 30µM L-TBA. In the presence or absence of L-TBA, the normalized 
time-integral of fEPSPs elicited by low frequency stimulation in the presence of Mg2+ did not 
change as peak amplitude varied over a range from approximately 200 µV to 2 mV (Figure 3D). 
This contrasts with the significant prolongation seen with increased release site density in the 
absence of Mg2+ (figure 2B). The kinetics of fEPSPs elicited at low frequency were also 
unchanged in the presence of L-TBA, in contrast to the effect of transport inhibition on NMDAR 
EPSCs in the absence of Mg2+ (figure 4.1B).  
 Unlike fEPSPs elicited at low frequency, the time-integrals of fEPSPs elicited by paired-
pulse facilitation were significantly increased function of peak amplitude the presence of Mg2+, 
inhibition of glutamate transport by 30 µM L-TBA resulted in a significant increase in the 
frequency-facilitated fEPSP time integral as function of peak amplitude (Figure 4.3E; least-
squares linear regression L-TBA: r =.43, p=0.004; control: r = 0.076, p=0.650). In the absence of 
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transport inhibition, the facilitated fEPSP kinetics were unchanged by changing release site 
density. 
!
!
Mechanism of frequency-dependent NMDAR facilitation 
!
  In order to examine the mechanism underlying the observed difference in frequency 
facilitation of AMPAR and NMDAR fEPSPs, we isolated NMDAR fEPSPs elicited by paired-
pulse stimulation in either the presence or absence of extracellular Mg2+. In the first set of 
experiments, NMDAR responses were isolated by recording fEPSPs in control ACSF containing 
1.2mM Mg2+ and subtracting responses in the presence of 50 µM APV. In the latter case, 
NMDAR fEPSPs were recorded in extracellular solution containing 20 µM CNQX with 0 Mg2+ 
(see Figure 4.2). The peak amplitude facilitation ratios of the compound fEPSP in control ACSF, 
the AMPAR-mediated fEPSP recorded in the presence of 50µM APV, and the NMDAR fEPSP 
recorded with CNQX in the absence of Mg2+ were not significantly different (Figure 4.4A-C).  In 
contrast, the facilitation ratio of the NMDAR fEPSP isolated by APV during recording in 
physiological ACSF with Mg2+ was significantly greater (Figure 4.4D,E; p<.001).  
!
!
!
!
!
!
!
!
!
!
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Figure 4.4. Paired pulse facilitation of NMDAR at the CA3-CA1 pyramidal neuron synapse 
in the presence and absence of 1.2 mM Mg2+. Paired-pulse fEPSPs (50 ms interval, 
normalized to first peak) of (A) fEPSP in control ACSF (B) AMPAR (50µM DL-APV), (C) NMDAR 
Mg-free +10µM CNQX, and (D) Physiological NMDAR (control-APV),  (E) Quantification of 
paired pulse ratio under different conditions. 
 These data suggested the possibility that selective enhancement of NMDAR signaling 
during repetitive activity may be due to a postsynaptic effect of Mg2+. To compare the interpulse 
interval-dependence of the NMDAR facilitation with that of the presynaptic release change 
reflected in facilitation of the AMPAR fEPSP, paired stimuli were delivered at varying interpulse 
intervals (Figure 4.5).  The time-dependent facilitation of the NMDAR signal was compared to 
that of the AMPAR signal, and the time-dependence of their mean relative amplitudes revealed 
that the NMDAR-selective frequency-enhancement decayed with a time constant of 238 ms 
(Figure 4.5B). We used the same analysis to compare the interpulse interval-dependence of the 
NMDAR signal isolated in the absence of Mg2+ with CNQX with the AMPAR signal. In this case, 
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the facilitation ratios and their frequency dependence were not different (Fig. 4.5C,D), 
suggesting a key role for physiological Mg2+ in generating the time course of NMDAR-selective 
frequency facilitation.   
!
!
!  
Figure 4.5. Physiological NMDAR signaling is limited by glutamate transport in a 
frequency- and Mg2+-dependent manner at the the CA3-CA1 pyramidal neuron synapse. 
(A) Normalized APV-sensitive component of the total fEPSP in the presence of 1.2mM Mg2+ 
(control - APV; red traces) AMPAR fEPSPs (black traces). (B) Summary of ratios of 
physiological NMDAR PPR (control-APV) and AMPAR PPR (n=9). Data points were fit to a 
single exponential decay function (time constant: 208ms) (C)  Normalized NMDAR fEPSP 
recorded in 0 Mg2+ and 10µM CNQX overlaid with AMPAR fEPSPs (black traces). (D) Summary 
of ratios between NMDAR PPR (0 Mg2+ /10µM CNQX ) and AMPAR PPR (n=6) . 
!
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Frequency- and Mg2+-dependent enhanced synaptic NMDAR signaling correlates with 
channel deactivation/desensitization kinetics 
 NMDAR receptors display slow decay kinetics following glutamate binding (Lester and Jahr, 
1992; Spruston et al., 1995;). We sought to test the possibility that Mg2+ played a role in the 
NMDAR-selective frequency facilitation through voltage-dependent unblock of receptors 
occupied by a previous synaptic glutamate transient. We compared the paired-pulse interval-
dependence of this synaptic facilitation with the time-dependence of responses to brief voltage 
pulses relieving Mg2+ unblock from NMDAR channels in outside-out patches at varying intervals 
following exposure to a transient glutamate concentration jump. In nucleated patches from 
visualized CA1 pyramidal neurons, the response to 5 ms voltage jumps relieving Mg2+ block 
slowly decayed as a function of the time interval following a 1ms exposure to 1 mM L-Glu 
(Figure 4.6). The decay time course of the currents matched the time-interval dependence of 
the synaptic facilitation reasonably well, with a fast time constant 148±12ms and a slow time 
constant of 521±73ms, mean single exponential fitting time constant was 227ms (Figure 4.6 
inset).  
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Figure 4.6. Determining glutamate unbinding rate using nucleated patch recording. 
Voltage jump induced NMDAR currents recorded from outside out patches with 1ms L-Glu 
application. Inset: Single exponential fitting of decay kinetics. Black dots, decay of voltage jump 
currents from outside out patches. Red dots, decay kinetics of normalized APV sensitive fEPSP. 
!
!
!
!
!
!
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Glutamate transport block alters the frequency-dependent NMDAR facilitation 
!
As indicated in figure 1 and 3, glutamate transport block significantly increase the occupancy of 
glutamate molecules on NMDAR after glutamate release. We thus tested the effect of transport 
block on the frequency dependent NMDAR facilitation. With 30µM TBA, the paired-pulse 
interval-dependence facilitation of NMDAR was significantly increased and prolonged compared 
to the facilitation time course in control condition. This facilitation exhibits a double exponential 
profile, with a fast tau 280ms and a slow tau of 3791ms (Fig. 4.7) 
!
   
Figure 4.7. TBA’s effect on frequency facilitation of NMDAR fEPSPs. (A) NMDAR 
component of the fEPSP (red traces) and AMPAR fEPSP (black traces) in the presence of 
1.2mM Mg2+ and 30µM TBA at interpulse intervals from 0 to 500ms (40 traces mean trace n=4). 
(B) Summary of ratios between NMDAR PPR (1.2mM Mg2+) and AMPAR PPR (n=6) with the 
presence of 30µM TBA (blue dots, double exponential fit: fast: 280ms slow: 3791ms).!
!
!
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Discussion!
Significant uncertainty surrounds the role of glutamate transport in modulating postsynaptic 
receptor responses, in part because the effects of uptake inhibition in CNS are region-
dependent. The use of transport blockers that vary in selectivity and mechanism may also 
contribute to heterogenous effects observed (see Tzingounis and Wadiche 2007). A general 
consensus emerging from work at the hippocampal Shaffer-CA1 pyramidal synapse is that 
transporter activity does not acutely modify synaptic AMPAR responses (Isaacson and Nicoll, 
1993; Sarantis et al., 1993; but see Tong and Jahr, 1996), while inhibition of transport or 
increasing presynaptic release leads to glutamate spillover and activation of extrasynaptic 
NMDAR receptors (Asztely et al., 1997; Lozovaya et al., 1999; Diamond, 2001, Arnth-Jensen et 
al. 2002; Scimemi et al., 2009). The central evidence for this conclusion comes from voltage 
clamp recordings of EPSCs under conditions where NMDAR activity is enabled, i.e. depolarized 
potentials or Mg2+-free solution (Mayer et al. 1984). An important limitation of voltage clamp in 
analyzing the influence of transport on synaptic responses arises because of the potential 
interplay between the kinetics of glutamate spillover and dynamic voltage changes influencing 
Mg2+ block of NMDARs. This is exemplified by the strong effects of postsynaptic voltage and 
Mg2+ on frequency-facilitation of NMDAR-dependent responses (Herron et al. 1986; Collingridge 
et al. 1987).  
 The results of this study show that fEPSPs resulting from low frequency (<.1 Hz) 
stimulation are virtually entirely mediated by AMPAR signaling, and that NMDAR signaling is 
only detected during brief repetitive activity involving as few as two stimuli at 5-10 Hz (Figure 
4.3). This frequency-dependent prolongation of fEPSPs through activation of NMDAR signaling 
occurred in physiological conditions with transport intact, and it was significantly enhanced by 
glutamate transport inhibition. During low frequency synaptic activity, however, inhibition of 
transport had minimal effect on fEPSP kinetics. In general, these results suggest that a 
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threshold for repetitive synaptic activity at approximately 5 Hz acts as a control switch for 
NMDAR signaling, and glutamate transport modulates the signal (Figure 4.5 and 4.7).  
 The interacting effects of frequency and transport on NMDAR signaling could 
theoretically arise in several ways. First, an increase in release probability throughout a 
frequency-facilitated set of inputs will result in an increase in the overall density of active release 
sites, which could tend to slow clearance and promote signaling through pooling of transmitter 
between sites (Otis et al. 1996). Consistent with previous work (Diamond, 2001; Arnth-Jensen et 
al., 2002), raising release site density by increasing stimulation intensity leads to enhanced 
transmitter binding to NMDARs, as directly revealed by NMDAR responses in permissive Mg2+-
free conditions (Figure 4.2B upper trace). In the presence of 1.2 mM [Mg2+], however, NMDAR 
signaling is not detectable over a range of stimulus strengths (Figure 4.2B lower trace). This 
suggests that the NMDAR signaling revealed by APV in frequency-facilitated fEPSPs recorded 
in physiological ACSF cannot be solely due to increased release site density. In addition to 
increasing release site density, presynaptic frequency facilitation can lead to increased synaptic 
glutamate concentrations by increasing the probability of multi-vesicular release at the Shaffer-
CA1 pyramidal cell synapse (Christie and Jahr, 2006). This is also not likely to be a major factor 
in enhanced NMDAR signaling, however, because enhancement of multi-vesicular release at 
low frequencies by elevating extracellular [Ca2+] does not prolong NMDAR EPSCs, although it 
does enhance the prolongation caused by glutamate transport inhibition (Christie and Jahr, 
2006). Another piece of evidence that distinguishes the mechanism of the frequency-dependent 
NMDAR signaling from presynaptic facilitation is that NMDAR responses increased with longer 
pulse trains, unlike the AMPA response facilitation (Figure 4.3). A third frequency-dependent 
mechanism that could in principle lead to enhanced NMDAR signaling is transporter saturation 
by glutamate pulses arriving at intervals more frequent than the transporter turnover rate. 
However, glial transporter cycling at 32°C is at least 10-fold faster than the 5-10 Hz frequency 
threshold for NMDAR signaling (Wadiche and Kavanaugh, 1998; Bergles and Jahr. 1998). 
Moreover, bursts of up to four stimuli at 100 Hz do not significantly impair glial transport in CA1 
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(Diamond and Jahr, 2000). However, the effect of pharmacological inhibition shows that during 
brief repetitive activity, glutamate transport significantly modulates the impact of increasing 
frequency and release site density on NMDAR signaling (Figure 4.3E).  
 Consistent with previous work, inhibition of transport during low frequency stimulation 
leads to enhanced NMDAR activity, as revealed by NMDAR responses in permissive Mg2+-free 
conditions (Figure 4.1). However, this effect of transport inhibition is not seen in physiological 
ACSF. Together, these data suggest that during low frequency synaptic transmission, activity of 
NMDARs is substantially prevented by Mg2+ block, and that during repetitive activity, glutamate 
transport cooperates with Mg2+ to limit NMDAR signaling. Modeling of transmitter diffusion in 
stratum radiatum in the absence of transport suggests glutamate could diffuse and bind to 
NMDARs associated with hundreds of synapses within 50 ms (Kullmann et al. 1999). In the 
absence of Mg2+, even with transport intact, glutamate binds to a significant number of NMDARs 
following a single stimulus, and the time course of the transmitter and receptor occupancy is 
significantly prolonged by increasing release site density (Figure 4.2B), repetitive activity (Figure 
4.1B1), or transport inhibition (Figure 4.3B).  
 It is clear from recordings in Mg2+-free conditions that many NMDARs are exposed to 
synaptic glutamate concentration profiles that are delayed by up to tens of milliseconds relative 
to AMPAR-mediated fEPSP decay (Figure 4.2B).  In physiological conditions, this time delay 
would tend to limit the voltage-dependent Mg2+ unblock of the NMDARs reached by the slow 
glutamate transient. The time delay is further influenced by release site density (Figure 4.2B) 
and glutamate transport (Figure 4.7), which would also influence the effective volume of 
transmitter action.  
 Together the data indicate that low frequency synaptic activity gives rise to a population 
of NMDARs that are occupied by glutamate but blocked by Mg2+; these silent NMDARs are 
primed for activation by subsequent synaptic activity occurring within a time window dependent 
on the unbinding rate of glutamate from the receptors. Because glutamate unbinding from 
NMDARs is relatively slow, with a time constant of approximately 200 ms (Lester and Jahr, 
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1992), activity mediated by such a primed pool of receptors would occur during repetitive activity 
in excess of ~5 Hz. This rate is in agreement with the measured exponential decay of the inter-
stimulus interval we found to activate NMDAR signaling (Figure 4.5, 238ms).. Although voltage-
dependent unbinding of Mg2+ from glutamate-occupied NMDARs displays complex multi-
exponential kinetics, substantial components have time constants in the sub-millisecond range 
(Kampa et al. 2004), which would allow primed NMDARs activity to essentially follow 
electrotonic dendritic responses. In addition to frequency, the interaction of release site density 
and transmitter transport would be expected to influence the size and response of the pool of 
primed receptors.  
  NMDAR channel kinetics play a critical role in this priming model, in particular the 
unbinding rates for glutamate (Lester and Jahr, 1992; Lester et al., 1990) and Mg2+ (Mayer et al. 
1984; Kampa et al., 2004). Together these rates provide a mechanism for frequency tuning 
NMDAR responses to repetitive activity near the glutamate unbinding rate, with the onset of 
activity delayed by one EPSP cycle. This mechanism would be congruent with the minimal 
requirements of two stimuli for induction of NMDAR-dependent LTP, in which a single synaptic 
event can prime a postsynaptic neuron such that a subsequent synaptic event within an 
appropriate time window leads to LTP (Larson and Lynch, 1986). It is notable that 5-10 Hz theta 
oscillations, which are associated with NMDAR-dependent plasticity in the hippocampus 
(Buzsaki, 2002), are also near the theoretical threshold frequency determined by transmitter 
unbinding. This priming mechanism further suggests the possibility that the glutamate affinity 
and desensitization kinetics of AMPARs could influence the synapse specificity of frequency-
dependent NMDAR signaling and LTP induction by favoring Mg unblock in response to the 
sharper concentration transients coming from closer release sites. Overall, the data indicate that 
the activity of glutamate transporters is tightly integrated with receptor kinetics to cooperatively 
control the effects of release site density and frequency on synaptic signaling. 
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CHAPTER 5: CONCLUSIONS 
In these studies, we investigated glutamate transporter’s two important functions in the brain: 
modulation of ambient glutamate and synaptic glutamate levels. By in vitro expressing 
glutamate transporters using Xenopus oocyte system, we monitored surface [Glu] as a function 
of transporter density and confirmed that high density of transporters are capable of maintaining 
<100nM [Glu] on the surface. With mathematical modeling, we propose that tonic glutamate 
release in a thin damaged layer near the probe could be a potential cause for the 1000 fold 
discrepancy of measured ambient glutamate levels between microdialysis and 
electrophysiological methods. Further, using novel transporter inhibitor L-TBA, we established 
the specificity and actions of this compound at schaffer collateral synapses in hippocampus and 
studied the modulation of NMDAR activation by transporters under physiological conditions. We 
conclude that glutamate transporters, Mg2+ and intrinsic kinetics of NMDAR cooperatively 
determine the frequency activation pattern of NMDAR and potentially its downstream signaling 
pathways such as long term potentiation. Together, these data demonstrated glutamate 
transporter’s wide concentrational and temporal dynamic range in modulating glutamate signals 
and its critical roles in maintaining normal brain function. Further studies on the kinetics and 
structural differences among the 5 EAAT subtypes would further deepen our understanding on 
the significance of co-expression of different transporter subtypes in the same brain region and 
transporter’s structural roles in capturing glutamate.
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